Vitor Augusto Ferreira SANTOS

Dr. Vitor Augusto Ferreira SANTOS

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2023 in Revista Brasileira de Farmacognosia
Verified
Journal Article
Closed access
PDF file
MLMaria Gabriela Sampaio Lira
Maria Gabriela Sampaio Lira
RNRanielly Araujo Nogueira
Ranielly Araujo Nogueira
ILIrlla Correia Lima Licá
Irlla Correia Lima Licá
GFGleycka Cristine Carvalho Gomes Frazão
Gleycka Cristine Carvalho Gomes Frazão
VSVitor Augusto Ferreira SANTOS
Vitor Augusto Ferreira SANTOS
FNFlávia Raquel Fernandes Nascimento
Flávia Raquel Fernandes Nascimento

15 September 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
VSVitor Augusto Ferreira SANTOS
Vitor Augusto Ferreira SANTOS
ILIrlla Correia Lima Licá
Irlla Correia Lima Licá
GFGleycka Cristine Carvalho Gomes Frazão
Gleycka Cristine Carvalho Gomes Frazão
RNRanielly Araujo Nogueira
Ranielly Araujo Nogueira
MLMaria Gabriela Sampaio Lira
Maria Gabriela Sampaio Lira
FNFlávia Raquel Fernandes Nascimento
Flávia Raquel Fernandes Nascimento
Propolis has potential anthelmintic activity against Schistosoma mansoni, although its mechanisms remain poorly characterized. This study evaluated the biological effects of standardized Apis mellifera propolis extract (EPP-AF®) in experimental murine schistosomiasis. In vitro, EPP-AF® reduced adult worm viability and motility. In vivo, Swiss mice were allocated to four groups: EPP-AF® (4.5 mg/kg/day, orally, for 30 days), Praziquantel (PZQ; 50 mg/kg, days 45–51 post-infection), infected untreated control, and uninfected untreated SHAM control. EPP-AF® delayed oviposition and reduced egg production and tissue retention, granuloma formation, hepatic fibrosis, and eosinophilia. It also modulated splenic cytokine production, reducing inflammatory mediators and increasing IL-10. Molecular docking indicated favorable interactions between propolis phenolic compounds and SmCB1. Collectively, EPP-AF® exhibited antiparasitic and tissue-protective effects during experimental S. mansoni infection, supporting its pharmacological potential against schistosomiasis.